Arkolith/Insider Trading/PBLS/Form 4

Sebulsky Alan

DirectorParabilis Medicines, Inc. (PBLS) · full profile →Form 4 · filed Jun 16, 2026
Net Buying
Open-Market Buys
$474K
Open-Market Sells
$0
Net Open-Market Flow
$474K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Buy(P)5K$26.00$130K26K
Jun 15, 2026Buy(P)4K$27.10$110K30K
Jun 12, 2026Buy(P)8K$27.67$233K21K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-273013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML